The prognosis of cholesterol embolism is often poor, and no treatment
is presently available. We report the use of a stable prostacyclin ana
logue in treating cholesterol embolism in a diabetic patient with arte
riopathy. As a sole therapy, it improved cutaneous manifestations and
pain, in parallel with an increased transcutaneous oxymetry. We think
that prostacyclin analogues are novel candidates for the treatment of
cholesterol embolism. (C) 1998 by John Wiley & Sons, Ltd.